Hanne Bak

899 total citations
33 papers, 701 citations indexed

About

Hanne Bak is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, Hanne Bak has authored 33 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Genetics. Recurrent topics in Hanne Bak's work include Protein purification and stability (14 papers), Viral Infectious Diseases and Gene Expression in Insects (11 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Hanne Bak is often cited by papers focused on Protein purification and stability (14 papers), Viral Infectious Diseases and Gene Expression in Insects (11 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Hanne Bak collaborates with scholars based in United States, United Kingdom and Denmark. Hanne Bak's co-authors include Andrew D. Tustian, Benjamin Adams, Owen R.T. Thomas, А. Н. Томилин, Gerrit Vriend, Sebastian A. Leidel, Attila Reményi, Matthias Wilmanns, Hans R. Schöler and Ning Li and has published in prestigious journals such as Cell, Chemical Engineering Science and Pharmaceutical Research.

In The Last Decade

Hanne Bak

32 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hanne Bak United States	13	511	218	131	76	69	33	701
Mai H. Tran United States	11	574 1.1×	121 0.6×	61 0.5×	143 1.9×	36 0.5×	13	1.2k
A. Kitayama Japan	6	491 1.0×	171 0.8×	41 0.3×	105 1.4×	37 0.5×	8	678
Qinwei Shi Canada	6	214 0.4×	70 0.3×	88 0.7×	110 1.4×	14 0.2×	7	498
Régis Sodoyer France	14	320 0.6×	109 0.5×	67 0.5×	120 1.6×	35 0.5×	24	545
B. Vijayalakshmi Ayyar United States	16	369 0.7×	256 1.2×	205 1.6×	74 1.0×	80 1.2×	25	988
Karl D. Brune United Kingdom	8	446 0.9×	215 1.0×	39 0.3×	111 1.5×	68 1.0×	8	725
Raffaele Ieva France	19	887 1.7×	41 0.2×	520 4.0×	51 0.7×	22 0.3×	31	1.3k
Johannes Urban Germany	10	949 1.9×	36 0.2×	441 3.4×	34 0.4×	77 1.1×	12	1.1k
Debora Barnett Foster Canada	15	265 0.5×	118 0.5×	123 0.9×	112 1.5×	28 0.4×	28	712
Marc H.V. Van Regenmortel France	7	320 0.6×	216 1.0×	28 0.2×	99 1.3×	21 0.3×	8	489

Countries citing papers authored by Hanne Bak

Since Specialization

Citations

This map shows the geographic impact of Hanne Bak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanne Bak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanne Bak more than expected).

Fields of papers citing papers by Hanne Bak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanne Bak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanne Bak. The network helps show where Hanne Bak may publish in the future.

Co-authorship network of co-authors of Hanne Bak

This figure shows the co-authorship network connecting the top 25 collaborators of Hanne Bak. A scholar is included among the top collaborators of Hanne Bak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanne Bak. Hanne Bak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reeves, John Τ., et al.. (2025). Development of cell-based assay for detecting replication-competent adeno-associated virus by qPCR. Molecular Therapy — Methods & Clinical Development. 33(3). 101529–101529.

Thakur, Garima, et al.. (2025). A two-pass anion-exchange chromatography strategy for enrichment of full capsids in manufacturing of adeno-associated viral vectors. Molecular Therapy — Methods & Clinical Development. 33(2). 101441–101441. 3 indexed citations

Thakur, Garima, Sheldon Mink, Hanne Bak, & Andrew D. Tustian. (2024). Single-use chromatographic clarification to eliminate endonuclease treatment in production of recombinant adeno-associated viral vectors. Separation and Purification Technology. 354. 128557–128557. 3 indexed citations

Thakur, Garima, Sheldon Mink, Hanne Bak, & Andrew D. Tustian. (2024). Improving process efficiency to reduce cost-of-goods per dose in manufacturing of recombinant AAVs. Cell and Gene Therapy Insights. 10(3). 479–499. 1 indexed citations

Zhong, Xuefei, Yuan Mao, Shawn Lawrence, et al.. (2023). Kinetics of Trisulfide-to-Disulfide Conversion of Therapeutic IgG1 Monoclonal Antibodies Under Physiological Conditions: A Case Study of Casirivimab And Imdevimab. Journal of Pharmaceutical Sciences. 113(3). 642–646. 2 indexed citations

Thakur, Garima, Sheldon Mink, Hanne Bak, & Andrew D. Tustian. (2023). Opportunities to implement continuous processing in production of recombinant adeno-associated viral vectors. Cell and Gene Therapy Insights. 9(3). 563–579–563–579. 2 indexed citations

Reilly, J.J., et al.. (2022). Identification of the specific causes of polysorbate 20 degradation in monoclonal antibody formulations containing multiple lipases. Pharmaceutical Research. 39(1). 75–87. 28 indexed citations

Molden, Rosalynn C., J.J. Reilly, Haibo Qiu, et al.. (2021). Host cell protein profiling of commercial therapeutic protein drugs as a benchmark for monoclonal antibody-based therapeutic protein development. mAbs. 13(1). 1955811–1955811. 42 indexed citations

Xiao, Hui, Michael A. Goren, Darya Burakov, et al.. (2020). Putative Phospholipase B-Like 2 is Not Responsible for Polysorbate Degradation in Monoclonal Antibody Drug Products. Journal of Pharmaceutical Sciences. 109(9). 2710–2718. 29 indexed citations

10.

Chen, Zhengwei, et al.. (2020). A general evidence-based sequence variant control limit for recombinant therapeutic protein development. mAbs. 12(1). 12 indexed citations

11.

Tustian, Andrew D., et al.. (2018). Development of a novel affinity chromatography resin for platform purification of bispecific antibodies with modified protein a binding avidity. Biotechnology Progress. 34(3). 650–658. 21 indexed citations

12.

Tustian, Andrew D., et al.. (2016). Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity. mAbs. 8(4). 828–838. 92 indexed citations

13.

Bak, Hanne, et al.. (2009). Reduced use of antimicrobials after vaccination of pigs against porcine proliferative enteropathy in a Danish SPF herd. Acta veterinaria Scandinavica. 51(1). 1–1. 78 indexed citations

14.

Bak, Hanne, et al.. (2009). Strategy to reduce antibiotic use in Danish nurseries and finishing units. International Conference on the Epidemiology and Control of Biological, Chemical and Physical Hazards in Pigs and Pork. 337–340. 3 indexed citations

15.

Bak, Hanne & Owen R.T. Thomas. (2006). Evaluation of commercial chromatographic adsorbents for the direct capture of polyclonal rabbit antibodies from clarified antiserum. Journal of Chromatography B. 848(1). 116–130. 50 indexed citations

16.

Bak, Hanne, et al.. (2006). Quality control using a multilevel logistic model for the Danish pig Salmonella surveillance antibody-ELISA programme. Preventive Veterinary Medicine. 78(2). 130–141. 1 indexed citations

17.

Bak, Hanne, Owen R.T. Thomas, & Jens Abildskov. (2006). Lumped parameter model for prediction of initial breakthrough profiles for the chromatographic capture of antibodies from a complex feedstock. Journal of Chromatography B. 848(1). 131–141. 18 indexed citations

18.

Bak, Hanne, et al.. (2006). High-throughput immunoturbidimetric assays for in-process determination of polyclonal antibody concentration and functionality in crude samples. Journal of Chromatography B. 848(1). 142–150. 4 indexed citations

19.

Bak, Hanne, et al.. (2002). Bacterial Colonization and Invasion in Pigs Experimentally Exposed to Streptococcus suis Serotype 2 in Aerosol. Journal of Veterinary Medicine Series B. 49(5). 211–215. 30 indexed citations

20.

Томилин, А. Н., Attila Reményi, Hanne Bak, et al.. (2000). Synergism with the Coactivator OBF-1 (OCA-B, BOB-1) Is Mediated by a Specific POU Dimer Configuration. Cell. 103(6). 853–864. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact